Correction to - An Unusual Etiology of Recurrent Parathyroid Hormone-Independent Hypercalcemia - Abstract, Abbreviations, and Case Presentation Updates

Sep 29, 2026

Correction notice for the JCEM Case Reports article “An Unusual Etiology of Recurrent Parathyroid Hormone–Independent Hypercalcemia” (2025; doi:10.1210/jcemcr/luaf271). Errors are identified in the Abstract, Abbreviations, and Case Presentation sections, where “acetylcholine esterase” is corrected to “angiotensin-converting enzyme (ACE)” in narrative text and abbreviation lists. The updated Case Presentation sentence replaces “serum acetylcholine esterase” with “serum angiotensin-converting enzyme (ACE),” aligning reported findings and terminology.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages1

Reading Time3 min

AccessFree to download

Correction Notice

Article and Correction Scope

Abstract Correction

Abbreviations Correction

Case Presentation Correction

Publication and Licensing Notes

JCEM Case Reports, 2026, 4, luaf323 [https://doi.org/10.1210/jcemcr/luaf323](https://doi.org/10.1210/jcemcr/luaf323)[ ](https://doi.org/10.1210/jcemcr/luaf323)Advance access publication 6 January 2026 Correction Correction to: “An Unusual Etiology of Recurrent Parathyroid Hormone–Independent Hypercalcemia” In the above-named article by Thakkar S, Bhattacharya S, Sobti P, Shankar M, Gill BS, and Mithal A (JCEM Case Reports. 2025, 3(12); doi: 10.1210/jcemcr/luaf271), there were errors in the Abstract, Abbreviations, and Case Presentation section. In the originally published article, in the Abstract, the third sentence read,“In view of elevated serum acetylcholine esterase and 1,25-dihydroxyvitamin D, a granulomatous etiology was suspected.” In the corrected article,“acetylcholine esterase” has been changed to “angiotensin-converting enzyme (ACE)” and the sentence now reads as,“In view of elevated serum angiotensin-converting enzyme (ACE) and 1,25-hydroxyvitamin D, a granulomatous etiology was suspected.” In the originally published article, in the Abbreviations section, the list read as, “Abbreviations: 1,25(OH)2D, 1,25-dihydroxyvitamin D; ACE, acetylcholine esterase; CPK, creatine phosphokinase; CT, computed tomography; FDG, 18F-fluorodeoxyglucose; PET, positron emission tomography; PTH, parathyroid hormone; Th, T-helper cell.” In the corrected article, the first two abbreviations have been changed to “1,25(OH)2D, 1,25-dihydroxyvitamin D” and “ACE, angiotensin-converting enzyme” and the list now reads as,“Abbreviations: 1,25(OH)2D, 1,25-dihydroxyvitamin D; ACE, angiotensin-converting enzyme; CPK, creatine phosphokinase; CT, computed tomography; FDG, 18F-fluorodeoxyglucose; PET, positron emission tomography; PTH, parathyroid hormone; Th, T-helper cell.” In the originally published article, in the Case Presentation section, the third sentence read,“A granulomatous etiology was suspected, as the serum acetylcholine esterase (ACE) and 1,25(OH)2D level was elevated (190 pg/mL [SI 456 pmol/L])(reference range, 18-72 pg/mL [SI: 43-172 pmol/L]) . Abdominal ultrasound, contrast-enhanced computed tomography.” In the corrected article,“serum acetylcholine esterase”has been changed to “serum angiotensin-converting enzyme,”and the sentence now reads as,“A granulomatous etiology was suspected, as the serum angiotensin-converting enzyme (ACE) and 1,25(OH)2D level was elevated (190 pg/mL [SI 456 pmol/L]) (reference range, 18-72 pg/mL [SI: 43-172 pmol/L]) .” The article has been corrected online. doi: 10.1210/jcemcr/luaf271 Corrected and Typeset: 6 January 2026 © The Author(s) 2026. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ([https://creativecommons](https://creativecommons). org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [journals.permissions@oup.com. See](journals.permissions@oup.com. See) the journal About page for additional terms.

FAQs

What article is being corrected?

The correction applies to the JCEM Case Reports article “An Unusual Etiology of Recurrent Parathyroid Hormone–Independent Hypercalcemia” (JCEM Case Reports. 2025, 3(12); doi:10.1210/jcemcr/luaf271).

What specific term was changed in the Abstract?

The Abstract changes “acetylcholine esterase” to “angiotensin-converting enzyme (ACE),” keeping the rest of the sentence consistent with the corrected wording.

What changes were made in the Abbreviations and Case Presentation sections?

In Abbreviations, “ACE” is corrected to “angiotensin-converting enzyme” instead of “acetylcholine esterase.” In Case Presentation, “serum acetylcholine esterase” is replaced with “serum angiotensin-converting enzyme (ACE),” updating the third sentence accordingly.

Sep 29, 2026

Uploaded by Taylor Morgan